From new technologies to physician autonomy, here are five leaders’ perspectives on where the GI industry is headed.
Latha Alaparthi, MD. President and Chair of the Board of Directors of the Digestive Health Physicians Association (Silver Spring, Md.): In GI, I’m really excited about newer medications, [such as] other modes of delivery where there’s cognitive behavioral therapy or alternative therapies for some of these psychosomatic issues that we tackle on a day-to-day basis and all the [artificial intelligence] and database delivery changes that we may make. I don’t know what the data actually will bring us in terms of interventions that we can change, but I think we are just at the beginning of collecting data since [electronic health records] have become so widely adapted now. It’ll be interesting to see that information play out in the next few years as well. Read More at Becker’s >>